Job title: Chief Scientific Officer
Senior research and development director with 25 years of experience in pharmaceutical industry, oncology, vascular biology and immune-inflammation, a strong experience in science, people management and project leadership and evaluation, and recognized expertise in translational and development strategy in oncology.
Previous positions: Executive vice president (EVP) Oncology EVOTEC – Senior vice president (SVP) Early to candidate Department SANOFI.
Membership to Committees and boards – Coordinator of major collaborations in discovery and translational medicine projects – Member of Joint Steering Committees for international research collaborations – Active and frequent participations in the evaluation of external opportunities (compounds – technologies).
Author of 75 publications and co-inventor of 25 patents.
Introducing OX401, a Next Generation PARP Inhibitor Able to Exploit Metabolic Vulnerabilities of Cancer Cells and Inducing a Potent STING Response 2:30 pm
day: Day Two